z-logo
open-access-imgOpen Access
Alteration of glucocorticoid receptors and exacerbation of inflammation during lytic cytomegalovirus infection in THP ‐1 cells
Author(s) -
Wang Shujun,
Dou Yaling,
Yang Hong,
Ni Anping,
Zhang Rui,
Qian Jiaming
Publication year - 2017
Publication title -
febs open bio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.718
H-Index - 31
ISSN - 2211-5463
DOI - 10.1002/2211-5463.12334
Subject(s) - lytic cycle , glucocorticoid receptor , immunology , glucocorticoid , inflammation , cytokine , proinflammatory cytokine , tumor necrosis factor alpha , receptor , medicine , biology , virus
Cytomegalovirus ( CMV ) infection is associated with glucocorticoid resistance in ulcerative colitis (UC) and may exacerbate the disease course. However, the underlying pathogenicity remains unclear. The aim of this study was to explore possible underlying mechanisms during CMV latency and lytic infection in the human mononuclear cell line THP ‐1. Latent and activated CMV infection cell models were established. We performed real‐time PCR and western blotting to examine changes in glucocorticoid receptors ( GR s) during CMV latency and activation. Pro‐inflammatory and anti‐inflammatory cytokines were detected by ELISA . After UV ‐inactivated CMV infection, GRs and cytokines were also examined. The expression of GR s was elevated in the reactivation group. An increased ratio of GR β/α and phosphorylation of GR α in the CMV reactivation group may explain refractory response to steroids. During CMV lytic infection, pro‐inflammatory cytokines IL ‐6 and TNF ‐α increased remarkably and anti‐inflammatory cytokine IL ‐5 decreased, which may exacerbate UC. GR and cytokines were unchanged in the UV ‐inactivated CMV infection group. Changes in the number and function of GR s may account for glucocorticoid resistance in CMV reactivation. The imbalance of pro‐ and anti‐inflammatory cytokines may be related to severe inflammation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here